Author:
Voronova A. D.,Karsuntseva E. K.,Stepanova O. V.,Chadin A. V.,Shishkina V. V.,Andretsova S. S.,Fursa G. A.,Shport S. V.,Reshetov I. V.,Chekhonin V. P.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference47 articles.
1. Liu XY, Yang LP, Zhao L. Stem cell therapy for Alzheimer’s disease. World J. Stem Cells. 2020;12(8):787-802. doi: https://doi.org/10.4252/wjsc.v12.i8.787
2. Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur. J. Neurol. 2018;25(1):59-70. doi: https://doi.org/10.1111/ene.13439
3. Si Z, Wang X. Stem cell therapies in Alzheimer’s disease: applications for disease modeling. J. Pharmacol. Exp. Ther. 2021;377(2):207-217. doi: https://doi.org/10.1124/jpet.120.000324
4. Appleby BS, Cummings JL. Discovering new treatments for Alzheimer’s disease by repurposing approved medications. Curr. Top. Med. Chem. 2013;13(18):2306-2327. doi: https://doi.org/10.2174/15680266113136660162
5. Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Clin. Interv. Aging. 2008;3(2):211-225.